On September 14, the pharmaceutical company Eli Lilly and Company launched its official blog to cover health care policy and innovations.
Many drug companies (Pfizer, Sanofi Aventis, Merck, GlaxoSmithKline) are trying to capitalize on direct-to-consumer marketing with social media using Twitter, Facebook drug pages, and now blogs.
The problem for the pharmaceutical industry, as noted on pharma news blogs like LillyPad and Pharma Marketing Blog, is figuring out the "very best way to launch a new social media strategy" within a "heavily regulated industry."
Now trending via big pharma's social health media is counterfeit drug awareness/regulation, Stand Up 2 Cancer's campaign to support innovation/research and respiratory disease prevalence.
Here are some vlogs, blogs, social networks you might want to use to keep current with your drugmakers:
Eli Lilly: http://lillypad.lilly.com/
J&J (Johnson & Johnson): http://jnjbtw.com/
Sanofi Aventis: http://www.sanofi-aventis.tv/home/index.php
Boehringer Ingelheim: http://twitter.com/Boehringer